YMAB icon

Y-mAbs Therapeutics
YMAB

Overview Fund Activity

117 hedge funds and large institutions have $804M invested in Y-mAbs Therapeutics in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 55 increasing their positions, 32 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+3
Holders Change %
+2.63%
% of All Funds
2.06%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
18
Increased
55
Reduced
32
Closed
14
Calls
–
Puts
$496K
Net Calls
-$496K
Net Calls Change
-$496K

Top Buyers

1
State Street
1
State Street
Massachusetts
$51.7M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$91.3M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$46.8M
4
FLAM
4
First Light Asset Management
Minnesota
$28.6M
5
ACM
5
Ashford Capital Management
Delaware
$15.4M

Top Sellers

1
PCH
1
Polar Capital Holdings
United Kingdom
$243K
2
CAM
2
Cormorant Asset Management
Massachusetts
$37.2M
3
SFM
3
Sphera Funds Management
Israel
$0
4
PI
4
Putnam Investments
Massachusetts
$0
5
Axa
5
Axa
France
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CSS
126
Cubist Systematic Strategies
Connecticut
– -$265K -5,356 Closed
AB
127
Amalgamated Bank
New York
– -$236K -4,764 Closed
Zurich Cantonal Bank
128
Zurich Cantonal Bank
Switzerland
– -$92K -1,868 Closed
PHK
129
Point72 Hong Kong
Hong Kong
– -$29K -580 Closed
QT
130
Quantbot Technologies
New York
– -$9K -200 Closed
VAIA
131
Virtus Alternative Investment Advisers
Connecticut
– -$7K -147 Closed
2 3 4 5
6